Clinical Trials Browser

Phase 2 × Gallbladder Neoplasms × sintilimab × Clear all

NCT05757336 2023-03-07

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Phase 2 Recruiting

Gastrointestinal

Gallbladder Neoplasms